Search Clinical Trials
597,783 trials
ID
Status
Phase
Title
Sponsor
NCT07757789
Thrombocytopenia Trajectories in Antiphospholipid Syndrome: A Multicenter Cohort StudyNew Valley UniversityRecruitingNot Applicable
NCT07757789Recruiting
Not Applicable
Thrombocytopenia Trajectories in Antiphospholipid Syndrome: A Multicenter Cohort...New Valley University
NCT07757841
Real-World Effectiveness of Tezepelumab in Allergic Bronchopulmonary AspergillosisQianfoshan HospitalNot Yet RecruitingNot Applicable
NCT07757841Not Yet Recruiting
Not Applicable
Real-World Effectiveness of Tezepelumab in Allergic Bronchopulmonary Aspergillos...Qianfoshan Hospital
NCT07758907
Interference and Stability Evaluation of the Intelligent Fingerprinting Drug Screening SystemCenExelEnrolling By InvitationNot Applicable
NCT07758907Enrolling By Invitation
Not Applicable
Interference and Stability Evaluation of the Intelligent Fingerprinting Drug Scr...CenExel
NCT07757152
Phase I Clinical Study of ZL-65 Tablet in Healthy Adult Participants in ChinaChengdu Zenitar Biomedical Technology Co., LtdRecruitingPhase 1
NCT07757152Recruiting
Phase 1
Phase I Clinical Study of ZL-65 Tablet in Healthy Adult Participants in ChinaChengdu Zenitar Biomedica...
NCT07757139
High- and Moderate-Intensity Inspiratory Muscle Training on Diaphragm Ultrasound Parameters, Cognition, and Mental HealthHacettepe UniversityCompletedNot Applicable
NCT07757139Completed
Not Applicable
High- and Moderate-Intensity Inspiratory Muscle Training on Diaphragm Ultrasound...Hacettepe University
NCT07758647
NO-Meal Announcement in Automated Insulin Delivery (Open-source and Commercial) SystemsInstitut de Recherches Cliniques de MontrealNot Yet RecruitingNot Applicable
NCT07758647Not Yet Recruiting
Not Applicable
NO-Meal Announcement in Automated Insulin Delivery (Open-source and Commercial)...Institut de Recherches Cl...
NCT07758816
Advancing Integrated Therapies for Gaucher DiseaseSanofi-Yale External Research CollaborationRecruiting
NCT07758816Recruiting
—
Advancing Integrated Therapies for Gaucher DiseaseSanofi-Yale External Rese...
NCT07758257
Biodiversity and Human Functioning Following Acquired Cerebrovascular Lesions - Phase 2 (EspertaMente)Dr. Franco MolteniCompletedNot Applicable
NCT07758257Completed
Not Applicable
Biodiversity and Human Functioning Following Acquired Cerebrovascular Lesions -...Dr. Franco Molteni
NCT07757087
A Research Study to See How NNC0487-0111 Affects the Body's Energy Use After a Weight Loss in Adults Living With Obesity, Compared to a Low-calorie Diet or PlaceboNovo Nordisk A/SRecruitingPhase 1
NCT07757087Recruiting
Phase 1
A Research Study to See How NNC0487-0111 Affects the Body's Energy Use After a W...Novo Nordisk A/S
NCT07758400
A Study on the Efficacy and Safety of Microneedling for Male Androgenetic AlopeciaCheng ZhouNot Yet RecruitingNot Applicable
NCT07758400Not Yet Recruiting
Not Applicable
A Study on the Efficacy and Safety of Microneedling for Male Androgenetic Alopec...Cheng Zhou
NCT07758309
Online Games to Help Canadian and U.S. Adults Identify COVID-19 and Vaccine Misinformation: Three Sequential Randomized StudiesCanadian HeritageCompletedNot Applicable
NCT07758309Completed
Not Applicable
Online Games to Help Canadian and U.S. Adults Identify COVID-19 and Vaccine Misi...Canadian Heritage
NCT07758673
Genetically Engineered Cells (BAFFR-CAR T Cells) for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and B-cell Lymphoblastic LymphomaCity of Hope Medical CenterNot Yet RecruitingPhase 1
NCT07758673Not Yet Recruiting
Phase 1
Genetically Engineered Cells (BAFFR-CAR T Cells) for the Treatment of Relapsed o...City of Hope Medical Cent...
NCT07757854
Exposure Therapy for Reactivity to SymptomsKarolinska InstitutetNot Yet RecruitingNot Applicable
NCT07757854Not Yet Recruiting
Not Applicable
Exposure Therapy for Reactivity to SymptomsKarolinska Institutet
NCT07758621
SYS6010 vs Investigator's Choice of Monotherapy in Patients With Recurrent or Metastatic HNSCCCSPC Megalith Biopharmaceutical Co.,Ltd.Not Yet RecruitingPhase 3
NCT07758621Not Yet Recruiting
Phase 3
SYS6010 vs Investigator's Choice of Monotherapy in Patients With Recurrent or Me...CSPC Megalith Biopharmace...
NCT07758998
The Effect of Motivational Interviewing on Smoking Behavior Among Nursing StudentsMeral Feratoğlu ResearchNot Yet RecruitingNot Applicable
NCT07758998Not Yet Recruiting
Not Applicable
The Effect of Motivational Interviewing on Smoking Behavior Among Nursing Studen...Meral Feratoğlu Research
NCT07758075
A Phase II Clinical Study to Evaluate the Efficacy and Safety of SHR-1139 Injection in Patients With Plaque PsoriasisGuangdong Hengrui Pharmaceutical Co., LtdNot Yet RecruitingPhase 2
NCT07758075Not Yet Recruiting
Phase 2
A Phase II Clinical Study to Evaluate the Efficacy and Safety of SHR-1139 Inject...Guangdong Hengrui Pharmac...
NCT07757984
Regional Nerve Block for Upper Extremity Surgery in Patients With SarcopeniaChang Gung Memorial HospitalNot Yet Recruiting
NCT07757984Not Yet Recruiting
—
Regional Nerve Block for Upper Extremity Surgery in Patients With SarcopeniaChang Gung Memorial Hospi...
NCT07756658
The Effects of Tyrosol and Creatine on Exercise Performance and Cognition in Healthy AdultsApplied Science & Performance InstituteNot Yet RecruitingNot Applicable
NCT07756658Not Yet Recruiting
Not Applicable
The Effects of Tyrosol and Creatine on Exercise Performance and Cognition in Hea...Applied Science & Perform...
NCT07757191
DURATION-GC: FLOT Plus Durvalumab and TS-1 Plus Durvalumab for Resectable Gastric CancerTaipei Veterans General Hospital, TaiwanNot Yet RecruitingPhase 2
NCT07757191Not Yet Recruiting
Phase 2
DURATION-GC: FLOT Plus Durvalumab and TS-1 Plus Durvalumab for Resectable Gastri...Taipei Veterans General H...
NCT07758465
Effectiveness of DIR/Floortime™ in Children With Autism Spectrum DisorderGIFT UniversityCompletedNot Applicable
NCT07758465Completed
Not Applicable
Effectiveness of DIR/Floortime™ in Children With Autism Spectrum DisorderGIFT University
Result Breakdown
Not yet recruiting11 (55%)
Recruiting4 (20%)
Completed4 (20%)
Enrolling by invitation1 (5%)
not_applicable12 (60%)
Phase 13 (15%)
Not Specified2 (10%)
Phase 22 (10%)
Phase 31 (5%)